Taevas
United StatesMarket Entry & Growth in United States
The United States is the world's largest life-sciences market, and navigating FDA regulations, distributor networks, and KOL ecosystems demands a partner with deep local expertise. Taevas provides end-to-end market entry support so your brand reaches Amer
FDA Clearance
510(k) / PMA
cGMP Compliance
$670B+
Healthcare Market Size
#1
Global Pharma & Device Market
335M+
Population
50
States Covered
Industries We Support
Four Industries. One United States Team.
Select an industry to see regulatory pathways, services, and how Taevas supports your United States market entry.
Medical Devices & Equipment
U.S. Food and Drug Administration (FDA), Center for Devices and Radiological Health (CDRH)
The United States medical device market exceeds $180 billion annually and is the largest in the world, making FDA clearance or approval a critical milestone for any global manufacturer. The FDA classifies devices into Class I, II, and III based on risk, with pathways ranging from 510(k) premarket notification to the more rigorous Premarket Approval (PMA) process. Taevas guides manufacturers through every step, from pre-submission meetings with CDRH to post-market surveillance obligations, ensuring a compliant and commercially successful launch.
Regulatory Pathways
Moderate Risk
510(k) Premarket Notification
For Class II devices, the 510(k) pathway demonstrates substantial equivalence to a legally marketed predicate device. FDA review typically takes 90 to 180 days from submission acceptance.
High Risk
Premarket Approval (PMA)
Class III devices that sustain or support life require full PMA, the most stringent FDA pathway, involving comprehensive clinical data and a target review time of 180 days. Taevas prepares your technical file and manages FDA interactions throughout.
Mandatory
FDA Establishment Registration
All domestic and foreign device manufacturers must register their establishments with the FDA annually and list their devices in the FDA device database before commercial distribution in the United States.
Ongoing
Post-Market Surveillance & MDR
Manufacturers must submit Medical Device Reports (MDRs) for adverse events and maintain a robust post-market surveillance system, including corrections and removals reporting as required by 21 CFR Part 806.
Our Services for Medical Devices in India
Why Taevas United States
Why Global Brands Choose Taevas for United States
Taevas combines deep FDA regulatory expertise with commercial execution capabilities across all 50 states, giving life-sciences brands a single, accountable partner from first submission to sustained U.S. revenue growth.
Regulatory Expertise
FDA Regulatory Depth
Our team includes former FDA reviewers and CDRH, CDER, and CFSAN specialists who understand the agency's expectations from the inside, reducing submission cycles and minimizing Complete Response Letters for your products.
50-State Coverage
Nationwide Commercial Reach
Taevas operates across all 50 U.S. states with established distributor relationships in hospital, retail, and e-commerce channels, enabling rapid commercial deployment once regulatory clearance is achieved.
Speed to Market
Accelerated Time to Market
Our pre-submission strategy services, including FDA Q-Sub meeting preparation and parallel regulatory-commercial planning, are designed to shorten your U.S. market entry timeline by identifying and resolving issues before formal submission.
Network Access
Established KOL & Distributor Networks
We maintain active relationships with leading U.S. Key Opinion Leaders across medical specialties and with top-tier distributors in pharma, devices, supplements, and beauty, giving your brand immediate credibility and channel access.
Local Presence
Dedicated In-Market Teams
Unlike advisory-only firms, Taevas provides on-the-ground U.S. teams for field sales support, medical affairs, and account management, ensuring your brand is represented professionally at every touchpoint in the American market.
Multi-Sector Success
Proven Multi-Industry Track Record
Taevas has successfully supported market entry across medical devices, pharmaceuticals, personal care, and food and dietary supplements in the United States, giving clients the benefit of cross-sector regulatory and commercial intelligence.
Get Started
Ready to Enter the United States Market?
Whether you are pursuing FDA clearance for a medical device, filing an NDA for a pharmaceutical product, or launching a supplement brand nationwide, Taevas provides the regulatory expertise and commercial infrastructure to make your U.S. market entry a success.
Free United States assessment
FDA and CDRH regulatory specialists
Nationwide distributor and KOL network
End-to-end to revenue